Illumine Investment Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,163
Closed -$1.51M – 27
2026
Q1
$946K Buy
10,163
+46
+0.5% +$4.07K 0.73% 52
2025
Q4
$813K Buy
10,117
+86
+0.9% +$7.2K 0.59% 56
2025
Q3
$979K Buy
10,031
+93
+0.9% +$7.49K 0.7% 52
2025
Q2
$693K Buy
9,938
+207
+2% +$11.8K 0.55% 60
2025
Q1
$483K Buy
+9,731
New +$615K 0.4% 75

Other funds holding ACLS

Illumine Investment Management's ACLS Position: Q2 2026 in Review

Illumine Investment Management sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 10,163 shares — an estimated $1.51M sold.

Illumine Investment Management first reported a position in ACLS in Q1 2025 and held it in 5 quarters. The position peaked at $979K in Q3 2025. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Illumine Investment Management reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Illumine Investment Management sold 10,163 Axcelis shares in Q2 2026, an estimated $1.51M.
  • Illumine Investment Management first reported a position in Axcelis in Q1 2025 and held it in 5 quarters.
  • Illumine Investment Management's Axcelis position peaked at $979K in Q3 2025.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Illumine Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.